When tumor cells acquire the capacity to move around and invade other tissues, there is a risk of metastases and cancer treatment becomes more difficult. At the Institut Curie, CNRS Director of Research Philippe Chavrier and his group have just discovered how breast cancer cells break the bonds that tether them to the tumor.
The basement membrane around the mammary gland is a barrier to the spread of cancer cells. Three proteins in the tumor cells transport enzymes needed to perforate this barrier, and another protein puts these enzymes in the right place.
These discoveries, published in the 16 June 2008 issue of The Journal of Cell Biology and in Current Biology on 8 July 2008, shed light on the early mechanisms of the formation of metastases in certain breast cancers. These findings constitute an essential step in the quest for the early identification of highly invasive tumors, or even the blocking of formation of metastases.
Tissues are generally formed by cells arranged side by side. Epithelial cells cover an outer surface, such as the skin or an organ such as the mammary gland, and remain tightly bound together. This cohesion is vital to the body’s functioning, and the epithelial cells remain in position in their original tissue until they die. Sometimes, though, they detach and move away, and while such migration is essential during embryonic development as cells give rise to new tissues, when tumor cells break loose this often heralds the formation of metastases.
When tumor cells break loose
Tumor cells accumulate errors, become totally anarchic, and flout all the rules. Some even become detached from the tumor through complex and poorly understood mechanisms. The Membrane and Cytoskeleton Dynamics Group headed by Philippe Chavrier (UMR 144 CNRS/Institut Curie) has now shed new light on the way cells, in this case breast cancer cells, escape their shackles. The mammary gland is separated from the neighboring tissue by the basement membrane, which the tumor cells will have to cross before continuing on their way.
The cell first forms protrusions called invadopodia and anchors them in the basement membrane. These “feet” provide everything needed to breach the membrane. The tumor cells produce a whole range of proteases that degrade the proteins of the extracellular matrix that hems them in, part of which is the basement membrane. These proteases cut a hole in the basement membrane through which the cells can escape.
In a first publication, the researchers used a model of metastatic breast cancer cells to show that the proteins sec3, sec8 and IQGAP1 transport vesicles containing proteases to the invadopodia. Without sec3, sec8 and IQGAP1 the vesicles cannot be fastened to the ends of the invadopodia and so the cells fail to escape into the neighboring tissue. Before the proteases can degrade the membrane, they must first be released from the vesicles.
In a second publication, Philippe Chavrier and colleagues show that the protein Vamp7 fuses protease-containing vesicles with the membrane of tumor cells. Only then can the proteases at the ends of the invadopodia progressively erode the basement membrane of the mammary gland. Inactivation of Vamp7 greatly reduces the ability of the breast cancer cells to degrade the extracellular matrix.
So tumor cells can only escape from the mammary gland by accomplishing a whole series of modifications. Philippe Chavrier and his group have shown how they hijack cellular mechanisms to leave their original tissue, after which they can spread throughout the body and form metastases.
These discoveries may help to explain why certain breast cancers are more aggressive than others, or even to identify highly invasive tumors at an early stage. It is also conceivable that tumor invasion could be blocked by acting on the underlying mechanisms identified by Philippe Chavrier and colleagues.
Source: Institut Curie
Explore further: Synthetic macromolecules kill multidrug-resistant cancer cells